FENC
Price:
$6.21
Market Cap:
$170.33M
Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.[Read more]
Industry
Biotechnology
IPO Date
2017-09-15
Stock Exchange
NASDAQ
Ticker
FENC
According to Fennec Pharmaceuticals Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 162.11M. This represents a change of -25.95% compared to the average of 218.93M of the last 4 quarters.
The mean historical Enterprise Value of Fennec Pharmaceuticals Inc. over the last ten years is 121.46M. The current 162.11M Enterprise Value has changed 13.25% with respect to the historical average. Over the past ten years (40 quarters), FENC's Enterprise Value was at its highest in in the December 2023 quarter at 317.45M. The Enterprise Value was at its lowest in in the December 2015 quarter at 17.84M.
Average
121.46M
Median
106.89M
Minimum
17.94M
Maximum
315.85M
Discovering the peaks and valleys of Fennec Pharmaceuticals Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 426.02%
Maximum Annual Enterprise Value = 315.85M
Minimum Annual Increase = -32.78%
Minimum Annual Enterprise Value = 17.94M
Year | Enterprise Value | Change |
---|---|---|
2023 | 315.85M | 24.66% |
2022 | 253.37M | 157.71% |
2021 | 98.31M | -32.78% |
2020 | 146.25M | 26.65% |
2019 | 115.48M | 17.75% |
2018 | 98.07M | -19.59% |
2017 | 121.95M | 426.02% |
2016 | 23.18M | 29.22% |
2015 | 17.94M | -26.00% |
2014 | 24.25M | -14.53% |
The current Enterprise Value of Fennec Pharmaceuticals Inc. (FENC) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
222.51M
5-year avg
185.85M
10-year avg
121.46M
Fennec Pharmaceuticals Inc.’s Enterprise Value is greater than Molecular Partners AG (107.67M), greater than MediciNova, Inc. (61.90M), greater than Anebulo Pharmaceuticals, Inc. (31.01M), greater than Champions Oncology, Inc. (116.09M), greater than Cyteir Therapeutics, Inc. (-20511738.00), less than Keros Therapeutics, Inc. (182.09M), less than Janux Therapeutics, Inc. (3.28B), less than Edgewise Therapeutics, Inc. (2.80B), less than Harmony Biosciences Holdings, Inc. (1.79B), less than Ikena Oncology, Inc. (0), greater than Aerovate Therapeutics, Inc. (43.80M), greater than Eliem Therapeutics, Inc. (43.34M), less than Decibel Therapeutics, Inc. (0), greater than Olema Pharmaceuticals, Inc. (102.82M), less than Disc Medicine, Inc. (326.79M), less than Larimar Therapeutics, Inc. (1.71B), less than Orchestra BioMed Holdings, Inc. (222.97M), greater than null (154.52M),
Company | Enterprise Value | Market cap |
---|---|---|
107.67M | $200.54M | |
61.90M | $103.98M | |
31.01M | $32.42M | |
116.09M | $112.07M | |
-20511738.00 | $108.71M | |
182.09M | $693.49M | |
3.28B | $3.28B | |
2.80B | $2.84B | |
1.79B | $1.99B | |
0 | $80.59M | |
43.80M | $73.92M | |
43.34M | $342.68M | |
0 | $123.37M | |
102.82M | $360.98M | |
326.79M | $1.90B | |
1.71B | $252.67M | |
222.97M | $178.28M | |
154.52M | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Fennec Pharmaceuticals Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Fennec Pharmaceuticals Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Fennec Pharmaceuticals Inc.'s Enterprise Value?
What is the highest Enterprise Value for Fennec Pharmaceuticals Inc. (FENC)?
What is the 3-year average Enterprise Value for Fennec Pharmaceuticals Inc. (FENC)?
What is the 5-year average Enterprise Value for Fennec Pharmaceuticals Inc. (FENC)?
How does the current Enterprise Value for Fennec Pharmaceuticals Inc. (FENC) compare to its historical average?